Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)
Top Cited Papers
- 30 September 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 63 (3), 154-163
- https://doi.org/10.1016/j.jdermsci.2011.05.005
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Increased risk of acute myocardial infarction in patients with psoriasis: A 5-year population-based study in TaiwanJournal of the American Academy of Dermatology, 2011
- Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendationsJournal of the American Academy of Dermatology, 2010
- Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trialJournal of the American Academy of Dermatology, 2010
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe PsoriasisNew England Journal of Medicine, 2010
- Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trialBritish Journal of Dermatology, 2009
- Genetic evidence for involvement of the IL23 pathway in Thai psoriaticsArchiv für dermatologische Forschung, 2009
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)The Lancet, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)The Lancet, 2008
- A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease LociPLoS Genetics, 2008
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006